Integra LifeSciences Reports First Quarter 2022 Financial Results
April 27, 2022 06:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022
April 01, 2022 08:08 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial...
Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix
March 22, 2022 08:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company and pioneers in nerve repair, today announced...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance
February 23, 2022 06:00 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase
January 11, 2022 16:30 ET | Integra LifeSciences Holdings Corporation
Fourth quarter 2021 revenue is expected to be in a range of $404 million to $406 million, representing an increase of approximately 4% on a reported basis and an increase of approximately 8% on an...
Integra LifeSciences Reports Third Quarter 2021 Financial Results
November 02, 2021 06:00 ET | Integra LifeSciences Holdings Corporation
Third Quarter 2021 Highlights Revenues of $386.9 million increased 4.5% on a reported basis and 6.7% on an organic basis compared to the prior year;GAAP earnings per diluted share of $0.51,...
Integra LifeSciences Announces Jan De Witte as President and Chief Executive Officer
October 28, 2021 08:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has appointed Jan D....
Integra LifeSciences to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021
October 06, 2021 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2021 financial...
Integra LifeSciences Announces Participation in Upcoming Investor Conferences
September 02, 2021 16:01 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in...
Integra LifeSciences Reports Second Quarter 2021 Financial Results
July 28, 2021 06:00 ET | Integra LifeSciences Holdings Corporation
Second Quarter 2021 Highlights Revenues of $390.0 million increased 50.8% on a reported basis and 48.7% on an organic basis compared to the prior year;GAAP earnings per diluted share of $0.41,...